1. Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians

   • Dominic C. Marshall
   • Melissa Holloway
   • Sufyan Hussain

   Commentary Open access 22 August 2019 Pages: 1553 - 1564

   

2. Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes

   • Tomoya Mita
   • Naoto Katakami
   • Hirotaka Watada

   Study Protocol Open access 23 July 2019 Pages: 1565 - 1575

   

3. Glucocrinology of Modern Sulfonylureas: Clinical Evidence and Practice-Based Opinion from an International Expert Group

   • Sanjay Kalra
   • A. K. Das
   • Leszek Czupryniak

   Review Open access 02 July 2019 Pages: 1577 - 1593

4. SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

   • Amar Ali
   • Steve Bain
   • As part of The Improving Diabetes Steering Committee

   Review Open access 09 July 2019 Pages: 1595 - 1622

   

5. Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

   • Amar Ali
   • Steve Bain
   • As part of The Improving Diabetes Steering Committee

   Correction Open access 18 July 2019 Pages: 1623 - 1624

6. Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?

   • Gary Deed
   • John J. Atherton
   • Andrew Sindone

   Review Open access 10 July 2019 Pages: 1625 - 1643

   

7. Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force

   • Sanjay Kalra
   • Ashok Kumar Das
   • Manilka Sumanatilleke

   Review Open access 29 July 2019 Pages: 1645 - 1717

   

8. What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?

   • Marc Evans
   • Angharad R. Morgan
   • Zaheer Yousef

   Review Open access 13 August 2019 Pages: 1719 - 1731

   

9. Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes

   • Taichi Nagahisa
   • Yoshifumi Saisho

   Review 22 August 2019 Pages: 1733 - 1752

   

10. Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review

    • Michael Willis
    • Christian Asseburg
    • Cheryl Neslusan

    Review Open access 24 August 2019 Pages: 1753 - 1769

    

11. The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit

    • Dhiren K. Patel
    • Jodi Strong

    Review Open access 27 August 2019 Pages: 1771 - 1792

    

12. Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin

    • Marc Evans
    • Mathew Wilkinson
    • Angeliki Giannpolou

    Review Open access 04 September 2019 Pages: 1793 - 1800

    

13. Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study

    • Xu Liang
    • Yue Zhang
    • Xuan Li

    Original Research Open access 18 July 2019 Pages: 1801 - 1809

    

14. An Evaluation System of Fundus Photograph-Based Intelligent Diagnostic Technology for Diabetic Retinopathy and Applicability for Research

    • Wei-Hua Yang
    • Bo Zheng
    • Pei-Rong Lu

    Original Research Open access 09 July 2019 Pages: 1811 - 1822

    

15. Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes

    • Kentaro Okazaki
    • Tomotaka Shingaki
    • Lawrence Fisher

    Original Research Open access 08 July 2019 Pages: 1823 - 1834

    

16. Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study

    • Tomoho Noda
    • Emi Ebihara
    • Masamitsu Nakazato

    Original Research Open access 12 July 2019 Pages: 1835 - 1846

    

17. Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study

    • Edward B. Jude
    • Mark Nixon
    • Elisheva Lew

    Original Research Open access 18 July 2019 Pages: 1847 - 1858

    

18. Effect of Pars Plana Vitrectomy With or Without Cataract Surgery in Patients with Diabetes: A Systematic Review and Meta-Analysis

    • Kang Xiao
    • Yi-Chen Dong
    • Guang-Ming Wan

    Original Research Open access 25 July 2019 Pages: 1859 - 1868

    

19. Simplifying Complex Insulin Regimens While Preserving Good Glycemic Control in Type 2 Diabetes

    • Zoltán Taybani
    • Balázs Bótyik
    • Tamás Várkonyi

    Original Research Open access 25 July 2019 Pages: 1869 - 1878

    

20. Risk of Fractures Associated with Dipeptidyl Peptidase-4 Inhibitor Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    • Qing Chen
    • Ting Liu
    • Caifeng Yan

    Original Research Open access 26 July 2019 Pages: 1879 - 1892

    

21. Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain: Delphi Study Results from the Think Twice Program

    • Carlos Morillas
    • Javier Escalada
    • Antonio Pérez

    Original Research Open access 29 July 2019 Pages: 1893 - 1907

    

22. Healthcare Professionals’ Perceptions of Type 2 Diabetes Mellitus Care in the Mediterranean Region

    • Charles Savona-Ventura
    • Josanne Vassallo
    • the MGSD-Education Study Group

    Original Research Open access 31 July 2019 Pages: 1909 - 1920

23. Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in East Asians with Type 2 Diabetes: A Systematic Review and Meta-Analysis

    • Lidan Yang
    • Lin Zhang
    • Zhenmei An

    Original Research Open access 02 August 2019 Pages: 1921 - 1934

    

24. Cluster Analysis of Unhealthy Lifestyles among Elderly Adults with Prediabetes: A Cross-Sectional Study in Rural China

    • Xiaofen Wang
    • Hailiang Gao
    • Huilan Xu

    Original Research Open access 13 August 2019 Pages: 1935 - 1948

25. Risk Factors for Doxorubicin-Induced Serious Hyperglycaemia-Related Adverse Drug Reactions

    • Jincheng Yang
    • Yu Wang
    • Jianying Zhang

    Original Research Open access 19 August 2019 Pages: 1949 - 1957

    

26. Achieving a Preoperative Target HbA_1c of < 69 mmol/mol in Elective Vascular and Orthopedic Surgery: A Retrospective Single Center Observational Study

    • Celina Uppal
    • Andrew Blanshard
    • Ketan Dhatariya

    Original Research Open access 29 August 2019 Pages: 1959 - 1967

27. Meta-Analysis and Cost-Effectiveness Analysis of Insulin Glargine 100 U/mL Versus Insulin Degludec for the Treatment of Type 2 Diabetes in China

    • Wen Su
    • Chaoyun Li
    • Jianwei Xuan

    Original Research 03 September 2019 Pages: 1969 - 1984

    

28. Correction to: A Practical Guide to Delivering Nutritional Advice to People with Diabetes

    • Pamela A. Dyson

    Correction Open access 22 August 2019 Pages: 1985 - 1985